Serological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia. - Wikidata - awgldk - TriplyDB

Serological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia.

Serological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia.

http://www.wikidata.org/entity/Q33620823

about

Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions Translating tumor antigens into cancer vaccines Cervical Cancer: Development of Targeted Therapies Beyond Molecular Pathogenesis.Immunologic treatments for precancerous lesions and uterine cervical cancer.Human papillomavirus therapeutic vaccines: targeting viral antigens as immunotherapy for precancerous disease and cancer.Recent progress in vaccination against human papillomavirus-mediated cervical cancer.Targeted immunotherapy of high-grade cervical intra-epithelial neoplasia: Expectations from clinical trials.Emerging human papillomavirus vaccines

P2860

Q26777442-18635781-15D0-45E9-B971-B79B9EACCEF2 Q34484042-F8AF3C91-EEE1-4023-BEF7-824674158A5E Q37579334-F65592DB-9630-45FD-9194-162FA772C9F8 Q37703113-79FBDF62-056D-4FC3-8AA9-30C53F34DCBA Q38089937-BA65CEE9-293D-4A71-81BE-4A844534E890 Q38370782-334D839B-D0D8-4232-A942-D7679701E437 Q50052586-FC639DCE-1C8D-4BFD-822A-3D540B0A4401 Q56967486-AF2F1E1F-FD66-4C15-8CE0-9D4AED95C464

P2860

Serological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia.

http://www.wikidata.org/entity/Q33620823

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Serological response to an HPV ...... high-grade cervical dysplasia.

@ast

Serological response to an HPV ...... high-grade cervical dysplasia.

@en

type

label

Serological response to an HPV ...... high-grade cervical dysplasia.

@ast

Serological response to an HPV ...... high-grade cervical dysplasia.

@en

prefLabel

Serological response to an HPV ...... high-grade cervical dysplasia.

@ast

Serological response to an HPV ...... high-grade cervical dysplasia.

@en

P1433

Q33620823-3FB0E8C3-2314-431C-B6EF-89D9686E87AC

P1476

Q33620823-A8D83810-0BE1-485B-9B4E-B00C96EA3181

P2093

Q33620823-758AA02A-DCE5-4525-A10D-E23090521352

Q33620823-9E77BAAC-AC26-4B15-A123-0D400E1E23A0

Q33620823-9ED42B13-E0ED-4B3E-901B-6ACDDC2F6A3E

Q33620823-D014A9DA-4B61-4E4C-9CCE-A0FE74AFD4D5

Q33620823-F7AD8882-820B-44C0-AAFE-85D6A74D9129

P2860

Q33620823-00045A0F-DFF1-41B9-B763-997B8F65F06B

Q33620823-0B458F3F-E60B-4132-8152-28CAB0AC177B

Q33620823-1AAE4D34-EF0C-4E01-8692-6ECE16631B44

Q33620823-2584580A-11BD-4D57-84B0-4E530AAC9E0B

Q33620823-3D4B49BA-D890-4CE6-8F0A-38B0F925F378

Q33620823-43AA209B-7AD3-47D4-9C9E-0B83841C4D74

Q33620823-4A29A894-BCD1-44EC-AA71-4FB1B5AE7706

Q33620823-4A314E15-5954-43BD-89E5-B4A7B31133ED

Q33620823-64999CDB-AC16-4901-AF8F-E6E4A92C0410

Q33620823-65B7F50A-F3A9-4EAE-8CDF-5338BF555ABB

P304

Q33620823-2A1B2DAB-7EA7-47E4-8CC2-F99156144383

P31

Q33620823-4F0030CB-A5BE-4C7D-9816-E82989B6A695

P356

Q33620823-5D5EC3FC-23CE-4F45-B8C1-036BDF864E12

P407

Q33620823-D6D5CDC8-D54A-4C2D-A60B-0FA0A190373B

P433

Q33620823-407DA8E5-7227-45E8-90E4-B5324CFB6FBB

P478

Q33620823-7BF7F3F8-7037-44E7-8BCF-9AFC756EF522

P577

Q33620823-FBF69EBA-C16C-4F2C-B1CB-B02CEB29603E

P698

Q33620823-4FD98489-C7BB-432D-BBF5-095505B38B91

P932

Q33620823-02B6623E-CF1D-4A7B-B61F-F8594F0A326A

P356

J.YGYNO.2009.05.044

P1433

Gynecologic Oncology

P1476

Serological response to an HPV ...... high-grade cervical dysplasia.

@en

P2093

Koenraad Van Doorslaer

http://www.w3.org/2001/XMLSchema#string

Laura L Reimers

http://www.w3.org/2001/XMLSchema#string

Mark H Einstein

http://www.w3.org/2001/XMLSchema#string

Robert D Burk

http://www.w3.org/2001/XMLSchema#string

Yevgeniy Y Studentsov

http://www.w3.org/2001/XMLSchema#string

P2860

Papanicolaou smears and cervical inflammatory cytokine responses.

Epidemiologic classification of human papillomavirus types associated with cervical cancer

Cervical surgery and preterm birth.

The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes.

Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis

Enhanced enzyme-linked immunosorbent assay for detection of antibodies to virus-like particles of human papillomavirus

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.

Polymer-based enzyme-linked immunosorbent assay using human papillomavirus type 16 (HPV16) virus-like particles detects HPV16 clade-specific serologic responses

A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions

Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III

P304

208-212

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YGYNO.2009.05.044

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19555999

http://www.w3.org/2001/XMLSchema#string

P932

2813920

http://www.w3.org/2001/XMLSchema#string